Literature DB >> 21246364

Comparison of serological markers between ACPA⁺ and ACPA⁻ of RA patients.

Chunhua Xun1, Yong Zhao.   

Abstract

UNLABELLED: Anti-citrullinated protein/peptide antibodies (ACPA) have recently emerged as sensitive and specific serological markers of rheumatoid arthritis (RA), providing superior alternative of the rheumatoid factor (RF) test in the laboratory diagnostics of RA. We compare the change of serum RF, CRP, IgG, IgM, IgA, total complement, C3 and C4. The sera sample was collected from 123 patients with RA. ACPA were detected with ELISA, and RF, CRP and total complement (Ct), C3 and C4 were examined by automatic biochemical analyzer. Serum RF and total complement concentrations were significantly higher in ACPA+ than in ACPA-, but there were no correlation between ACPA and RF and Ct. Between ACPA+ and ACPA-, there were no significant difference of CRP, IgG, IgM, IgA, total complement, C3 and C4. While there were significant correlation between the concentration of C3 and IgM and ACPA in ACPA+.
CONCLUSION: This is the first study to show that ACPA concentration in ACPA+ patients with RA is positively related to serum IgM and C3 levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246364     DOI: 10.1007/s00296-010-1757-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.

Authors:  J P Brodeur; S Ruddy; L B Schwartz; G Moxley
Journal:  Arthritis Rheum       Date:  1991-12

2.  How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.

Authors:  Henk Visser; Saskia le Cessie; Koen Vos; Ferdinand C Breedveld; Johanna M W Hazes
Journal:  Arthritis Rheum       Date:  2002-02

3.  Local production of complement proteins in rheumatoid arthritis synovium.

Authors:  Elena Neumann; Scott R Barnum; Ingo H Tarner; Josh Echols; Martin Fleck; Martin Judex; Frank Kullmann; John D Mountz; Jürgen Schölmerich; Steffen Gay; Ulf Müller-Ladner
Journal:  Arthritis Rheum       Date:  2002-04

4.  Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.

Authors:  K N Verpoort; C M Jol-van der Zijde; E A M Papendrecht-van der Voort; A Ioan-Facsinay; J W Drijfhout; M J D van Tol; F C Breedveld; T W J Huizinga; R E M Toes
Journal:  Arthritis Rheum       Date:  2006-12

5.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.

Authors:  R Engelmann; J Brandt; M Eggert; K Karberg; A Krause; G Neeck; B Mueller-Hilke
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

7.  An analysis of the levels of complement components in the synovial fluid in rheumatic diseases.

Authors:  A J Swaak; A Van Rooyen; O Planten; H Han; O Hattink; E Hack
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

8.  High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.

Authors:  K Suzuki; T Sawada; A Murakami; T Matsui; S Tohma; K Nakazono; M Takemura; Y Takasaki; T Mimori; K Yamamoto
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

Review 9.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.